A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial

BACKGROUND: Azithromycin is an orally active synthetic macrolide antibiotic with a wide range of anti-bacterial, anti-inflammatory and antiviral properties. It is a safe, inexpensive, generic licenced drug available worldwide and manufactured to scale and is a potential candidate therapy for pandemi...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Trials
Main Authors: Hinks, Timothy S. C., Barber, Vicki S., Black, Joanna, Dutton, Susan J., Jabeen, Maisha, Melhorn, James, Rahman, Najib M, Richards, Duncan, Lasserson, Daniel, Pavord, Ian D., Bafadhel, Mona
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2020
נושאים:
Study Protocol
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7429453/
https://ncbi.nlm.nih.gov/pubmed/32807209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04593-8
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים